Email
Print
Amoxicillin Market Overview:
The Amoxicillin Market size is valued at $4.8 billion in 2022 and is expected to reach a value of $5.3 billion by 2030 at a CAGR of 1.2% during the forecast period 2023-2030. It is primarily used to treat bacterial infections such as pneumonia, bronchitis, and urinary tract infections. Amoxicillin is available in various forms such as tablets, capsules, and suspension. The amoxicillin market is expected to grow steadily in the coming years, driven by increasing demand for antibiotics to treat bacterial infections.
The growing prevalence of infectious diseases and the emergence of antibiotic-resistant bacteria are also expected to drive demand for amoxicillin and other antibiotics. The market for amoxicillin is highly competitive, with numerous generic manufacturers producing the drug. Some of the major players in the global amoxicillin market include Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Sanofi S.A., and GlaxoSmithKline plc.
However, the market is also faced with certain challenges such as the threat of antibiotic resistance and the side effects associated with the use of antibiotics. This has led to increased focus on the development of alternative treatment options such as probiotics and immunotherapy.
Amoxicillin Market - Report Coverage:
The “Amoxicillin Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Amoxicillin Market.
Amoxicillin Market - Top Trends:
Growing demand for generic amoxicillin: The demand for generic amoxicillin has been increasing due to its affordability compared to branded versions. This has led to a rise in the number of generic manufacturers, which has made the market more competitive.
Rising prevalence of bacterial infections: Bacterial infections continue to be a significant health concern, especially in developing countries. As such, the demand for antibiotics like amoxicillin is expected to rise, particularly in low- and middle-income countries where access to healthcare is limited.
Concerns about antibiotic resistance: Antibiotic resistance has been a growing concern in recent years, with many bacteria becoming resistant to commonly used antibiotics. This has led to increased efforts to develop new antibiotics and alternative treatment options.
Focus on combination therapies: Combination therapies involving amoxicillin and other antibiotics or drugs are gaining traction in the market. These therapies can be more effective in treating bacterial infections, particularly those caused by drug-resistant bacteria.
Increasing interest in probiotics and immunotherapy: The emergence of antibiotic resistance and concerns about the side effects of antibiotics have led to increased interest in alternative treatment options such as probiotics and immunotherapy. These options may provide a more targeted and sustainable approach to treating bacterial infections.
Amoxicillin Market - Company Product Analysis:
Teva Pharmaceutical Industries Ltd.: Teva produces a range of amoxicillin products, including tablets, capsules, and oral suspension. They offer different dosage strengths, ranging from 125 mg to 875 mg.
Novartis AG: Novartis produces Amoxil, a brand of amoxicillin that is available in the form of capsules, tablets, and oral suspension. They offer different dosage strengths, ranging from 250 mg to 500 mg.
Pfizer Inc.: Pfizer produces amoxicillin under the brand name Trimox, which is available in the form of capsules and oral suspension. They offer different dosage strengths, ranging from 250 mg to 500 mg.
Sanofi S.A.: Sanofi produces amoxicillin under the brand name Amoxil Pediatric Drops, which is available in the form of oral suspension. They offer different dosage strengths, ranging from 125 mg to 250 mg.
GlaxoSmithKline plc: GlaxoSmithKline produces amoxicillin under the brand name Augmentin, which is a combination of amoxicillin and clavulanic acid. Augmentin is available in the form of tablets, oral suspension, and intravenous injection. They offer different dosage strengths, ranging from 125 mg to 1000 mg.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Amoxicillin Market . The top 10 companies in this industry are listed below:
- Merck KGaA
- NCPC Xianati
- SPC Pharmaceutical Group Limited
- Sino pharm Weiqida
- Sandoz AG
- DAEWOONG CO.LTD.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Pfizer Inc.
- GlaxoSmithKline plc
Scope of Report:
For more Food and Beverage Market reports, please click here
1.Amoxicillin Market - Overview
1.1.Definitions and Scope
2.Amoxicillin Market - Executive Summary
3.Amoxicillin Market - Comparative Analysis
3.1.Company Benchmarking - Key Companies
3.2.Global Financial Analysis - Key Companies
3.3.Market Share Analysis - Key Companies
3.4.Patent Analysis
3.5.Pricing Analysis
4.Amoxicillin Market - Start-up Companies Scenario (Premium)
4.1.Key Start-up Company Analysis by
4.2.Investment
4.3.Revenue
4.4.Venture Capital and Funding Scenario
5.Amoxicillin Market – Market Entry Scenario Premium (Premium)
5.1.Regulatory Framework Overview
5.2.New Business and Ease of Doing Business Index
5.3.Case Studies of Successful Ventures
6.Amoxicillin Market - Forces
6.1.Market Drivers
6.2.Market Constraints
6.3.Market Challenges
6.4.Porter's Five Force Model
6.5.Bargaining Power of Suppliers
6.6.Bargaining Powers of Customers
6.7.Threat of New Entrants
6.8.Rivalry Among Existing Players
6.9.Threat of Substitutes
7.Amoxicillin Market – Strategic Analysis
7.1.Value Chain Analysis
7.2.Opportunities Analysis
7.3.Market Life Cycle
8.Amoxicillin Market – By FORMULATION (Market Size – $Million/$Billion)
8.1.Tablet
8.1.1.Key Market Trends, Growth Factors and Opportunities
8.1.2.Market Size and Forecast, By Region
8.1.3.Market Share Analysis, By Country
8.2.Capsule
8.2.1.Key Market Trends, Growth Factors and Opportunities
8.2.2.Market Size and Forecast, By Region
8.2.3.Market Share Analysis, By Country
8.3.Suspension
8.3.1.Key Market Trends, Growth Factors and Opportunities
8.3.2.Market Size and Forecast, By Region
8.3.3.Market Share Analysis, By Country
9.Amoxicillin Market – By Application (Market Size – $Million/$Billion)
9.1.Chest Infection
9.1.1.Key Market Trends, Growth Factors and Opportunities
9.1.2.Market Size and Forecast, By Region
9.1.3.Market Share Analysis, By Country
9.2.Skin Infection
9.2.1.Key Market Trends, Growth Factors and Opportunities
9.2.2.Market Size and Forecast, By Region
9.2.3.Market Share Analysis, By Country
9.3.Respiratory Tract Infection
9.3.1.Key Market Trends, Growth Factors and Opportunities
9.3.2.Market Size and Forecast, By Region
9.3.3.Market Share Analysis, By Country
9.4.Ear Infection
9.4.1.Key Market Trends, Growth Factors and Opportunities
9.4.2.Market Size and Forecast, By Region
9.4.3.Market Share Analysis, By Country
9.5.Kidney Infection
9.5.1.Key Market Trends, Growth Factors and Opportunities
9.5.2.Market Size and Forecast, By Region
9.5.3.Market Share Analysis, By Country
9.6.Others
9.6.1.Key Market Trends, Growth Factors and Opportunities
9.6.2.Market Size and Forecast, By Region
9.6.3.Market Share Analysis, By Country
10.Amoxicillin Market – By DISTRIBUTION CHANNEL (Market Size – $Million/$Billion)
10.1.Retail Pharmacies
10.1.1.Key Market Trends, Growth Factors and Opportunities
10.1.2.Market Size and Forecast, By Region
10.1.3.Market Share Analysis, By Country
10.2.Online Pharmacies
10.2.1.Key Market Trends, Growth Factors and Opportunities
10.2.2.Market Size and Forecast, By Region
10.2.3.Market Share Analysis, By Country
10.3.Others
10.3.1.Key Market Trends, Growth Factors and Opportunities
10.3.2.Market Size and Forecast, By Region
10.3.3.Market Share Analysis, By Country
11.Amoxicillin Market – by Geography (Market Size – $Million/$Billion)
11.1.North America
11.1.1.The U.S.
11.1.2.Canada
11.1.3.Mexico
11.2.Europe
11.2.1.UK
11.2.2.Germany
11.2.3.France
11.2.4.Italy
11.2.5.Spain
11.2.6.Russia
11.2.7.Rest of Europe
11.3.Asia-Pacific
11.3.1.China
11.3.2.India
11.3.3.Japan
11.3.4.South Korea
11.3.5.Australia & New Zealand
11.3.6.Rest of Asia-Pacific
11.4.South America
11.4.1.Brazil
11.4.2.Argentina
11.4.3.Chile
11.4.4.Colombia
11.4.5.Rest of South America
11.5.Rest of the World
11.5.1.Middle East
11.5.2.Africa
12.Amoxicillin Market – Entropy
13.Amoxicillin Market – Industry/Segment Competition Landscape Premium
13.1.Market Share Analysis
13.1.1.Market Share by Product Type – Key Companies
13.1.2.Market Share by Region – Key Companies
13.1.3.Market Share by Country – Key Companies
13.2.Competition Matrix
13.3.Best Practices for Companies
14.Amoxicillin Market – Key Company List by Country Premium Premium
15.Amoxicillin Market - Company Analysis
16.Teva Pharmaceutical Industries Ltd.
17.Novartis AG
18.Pfizer Inc.
19.Sanofi S.A.
20.GlaxoSmithKline plc
21.Aurobindo Pharma Limited
22.Lupin Limited
23.Mylan N.V.
24.Sun Pharmaceutical Industries Ltd.
25.Zydus Cadila
26.Alkem Laboratories Ltd.
27.Cipla Limited
28.Torrent Pharmaceuticals Ltd.
29.Hikma Pharmaceuticals PLC
30.Sandoz International GmbH
31.Wockhardt Limited
32.Intas Pharmaceuticals Ltd.
33.Ranbaxy Laboratories Ltd.
34.Antibioticos S.A.
35.Merck KGaA
36.NCPC Xianati
37.SPC Pharmaceutical Group Limited
38.Sinopharm Weiqida
39.Sandoz AG
40.DAEWOONG CO.LTD.
"Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our
reports include global-level data, niche markets and competitive landscape.
The Amoxicillin Market is projected to grow at 1.2% CAGR during the forecast period 2023-2030.
Global Amoxicillin Market size is estimated to reach $5.3 billion by 2030.
The leading players in the Amoxicillin Market are Merck KGaA, NCPC Xianati, SPC Pharmaceutical Group Limited, Sinopharm Weiqida, Sandoz AG.